![](https://img.einnews.com/small/834702/doxorubicin-market.png)
Doxorubicin Market to Grow at 6.8% CAGR, Reaching $1.81 Billion by 2034
Rising cancer cases and advancement like nanomaterials are driving demand for chemotherapy drugs. The doxorubicin market is expanding as a key treatment option. ROCKVILLE , MD, UNITED STATES, February 14, 2025 /EINPresswire.com/ -- The …